Institute for Clinical and Economic Review

Cancer Clinical Trials Drugs (Pharmaceuticals)Elderly Health Insurance and Managed Care Immunotherapy Institute for Clinical and Economic Review Longevity Pancreatic Cancer Prices (Fares, Fees and Rates)Revolution Medicines Inc

August 31, 2026 Rebecca Robbins

A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs

Rasonque, the new pancreatic cancer treatment from Revolution Medicines, illustrates the huge inflation in cancer drug prices over the past two decades.